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Abstract
We sought to determine whether diﬀerentiation agents such as retinoids and butyrate regulate transcript levels of interphoto-
receptor retinoid binding protein (IRBP) and cone rod homeobox (CRX), a homeodomain transcription factor that regulates IRBP
promoter activity. WERI-Rb1 retinoblastoma cells were treated with all-trans retinol, all-trans retinoic acid, or butyrate. IRBP and
CRX mRNA levels were determined by quantitative RT-PCR. Butyrate at low concentrations increased both mRNA levels but
suppressed them at higher concentrations. Retinoic acid had minimal eﬀects. Retinol increased CRX mRNA over four fold. IRBP
and CRX transcript levels are sensitive to butyrate and CRX expression is sensitive to retinol.  2002 Published by Elsevier Science
Ltd.
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1. Introduction
Interphotoreceptor retinoid binding protein (IRBP) is
a large glycolipoprotein that accumulates at high con-
centration in the interphotoreceptor space (IPS) (Bunt-
Milam & Saari, 1983; Carlson & Bok, 1992; Okajima,
Pepperberg, Ripps, Wiggert, & Chader, 1989; Okajima,
Pepperberg, Ripps, Wiggert, & Chader, 1990; van Veen
et al., 1986). Though its physiological role remains to be
determined, ablation of the IRBP gene leads to pro-
gressive visual dysfunction in knock-out mice (Liou, Fei,
et al., 1998).
IRBP expression is tightly restricted to photorecep-
tors of the retina and pinealocytes of the pineal gland in
mammals (Liou, Wang, & Matragoon, 1994; van Veen
et al., 1986), though this expression proﬁle may diﬀer in
other vertebrates (Stenkamp, Cunningham, Raymond,
& Gonzalez-Fernandez, 1998). Retinoids may regulate
IRBP levels. Treatment of retinoid-deprived rodents
with retinol increases IRBP immunoreactivity in the IPS
and retina (Katz, Gao, & Stientjes, 1993; Liou, Matra-
goon, et al., 1998), though possibly not through tran-
scription regulation (Liou, Matragoon, et al., 1998). As
the proximal IRBP promoter contains a conserved reti-
noic acid receptor element (RARE) (Boatright, Borst,
et al., 1997; Boatright, Nickerson, & Borst, 2000), reg-
ulation could be via activation of retinoic acid receptors
(RARs). Retinol can bind RARs (Giguere, Ong, Segui,
& Evans, 1987; Petkovich, Brand, Krust, & Chambon,
1987) and retinol can be metabolized to retinoic
acid, which also activates RARs (see Ross, McCaﬀery,
Drager, & DeLuca, 2000 for review). Alternatively,
potential regulation could be indirect. Retinoids in some
cases regulate terminal diﬀerentiation via homeodomain
proteins (Ross et al., 2000); IRBP promoter activity is
regulated by homeodomain proteins such as OTX2, Rx,
and CRX (Chen et al., 1997; Furukawa, Morrow, &
Cepko, 1997; Briata, Ilengo, Bobola, & Corte, 1999;
Bobola et al., 1999; Fong & Fong, 1999; Kimura et al.,
2000; Boatright, Borst, Stodulkova, & Nickerson, 2001).
To determine whether retinoids can aﬀect IRBP
mRNA levels, we examined the eﬀects of retinol and
retinoic acid on IRBP transcript levels in cultured
WERI-Rb1 retinoblastoma cells. We additionally tested
the eﬀects of butyrate, another diﬀerentiation agent
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previously shown to induce IRBP expression in retino-
blastoma cells (Kyritsis, Wiggert, Lee, & Chader, 1985).
Transcript levels of CRX, another photoreceptor-spe-
ciﬁc gene, and GAPDH, a ubiquitously-expressed gene,
were monitored also.
2. Methods
The CAT plasmid vectors used were based on the
promoterless CAT vector pBLCAT3 (GenBank Acces-
sion number X64409), which served as a negative con-
trol. Two IRBP promoter/CAT reporter plasmids, one
using a 1783 to þ101 fragment and the other a 156
to þ101 fragment of the murine IRBP sequence (Gen-
bank accession M32734), were constructed as previously
described (Boatright, Borst, et al., 1997; Boatright,
Buono, et al., 1997). Both contain a putative RARE at
113 to 110, relative to transcription start.
WERI-Rb1 retinoblastoma cells (HTB-169; ATCC,
Manassas, VA) were maintained as previously described
(Boatright, Borst, et al., 2001; Boatright, Knox, et al.,
2001). Cells were plated at 5 105 cells per 35 mm
culture well in 1 ml of growth medium and transfected
with plasmids or treated with drugs the same day.
Transfections were via Superfect (Qiagen; Valencia, CA)
as previously described (Boatright, Borst, et al., 2001;
Boatright, Knox, et al., 2001). For drug treatments, all
chemicals were purchased from Sigma Chemical Co., St.
Louis, MO. All-trans retinol and all-trans retinoic acid
were dissolved in 100% ethanol in dim red light and
stored at 80 C. Serial dilutions in ethanol were pre-
pared in dim red light immediately prior to addition to
cultures. Control cultures received ethanol without reti-
noids. A 1 M stock solution of n-butyric acid sodium
salt was dissolved in Opti-MEM I reduced serum me-
dium (GIBCO-BRL, Grand Island, NY) and serial di-
lutions of this were prepared in incubation medium
immediately prior to addition to cultures. Cells were
incubated for 16 h at 37 C in 5% CO2 following addi-
tion of transfection mixtures or drugs to culture media.
The decision to use a 16 h incubation was partially based
on previous work examining retinoid regulation of ho-
meobox genes (Bang, Papalopulu, Kintner, & Goulding,
1997; Chariot, Moreau, Senterre, Sobel, & Castronovo,
1995; Gaunt, 1991; Houle, Prinos, Iulianella, Bouchard,
& Lohnes, 2000; Lindberg, Wunderlich, Dinsmore, &
Jacoby, 1998; Simeone et al., 1991; Simeone et al., 1990).
Cells were assayed for CAT activity as previously
described (Boatright, Buono, et al., 1997). Brieﬂy, cell
cytoplasm solutes were mixed with tritiated acetyl-Co-
enzyme A and chloramphenicol and CAT activity
measured as the accumulation of 3H-acetylchloram-
phenicol over time. CAT activity is reported as CAT
enzyme units 105, and represent the mean of 3 repeats
SEM per group per experiment.
Real time reverse transcription PCR (RT-RT-PCR)
was performed on total RNA from cells as previously
described (Boatright, Borst, et al., 2001) with exceptions.
RNA and primers (see below) were added to Quantitect
SYBR Green RT-PCR master mix (QIAGEN Inc.,
Valencia, CA) as per manufacturer instructions. Reverse
transcription, PCR ampliﬁcation, and ﬂuorescence de-
tection of product were conducted using a Bio-Rad
iCycler iQ real time PCR detection system (Bio-Rad,
Hercules, CA). Relative mRNA concentrations were
estimated based on the number of PCR cycles required
to reach a threshold of PCR product ﬂuorescence
intensity. The threshold was taken as a value above
background corresponding to ten times rms noise of ﬂu-
orescence intensity across a window usually spanning
cycles 2 through 10. For each template RNA, threshold
cycle numbers (TCN) for IRBP and CRX reactions were
subtracted from TCN of GAPDH reactions to correct
for diﬀerences in total RNA starting concentration.
The eﬀect of treatment on relative mRNA concentra-
tion (i.e., the eﬀect on transcript levels) was taken as
ð1:95ðabÞÞ where a ¼ TCN for no treatment and b ¼
threshold cycle number for treatment. Data are fold-
change means  SEM.
Primers were designed to span introns (Boatright,
Borst, et al., 2001) and were as follows (forward then
reverse, respectively): GAPDH, 50-GCC AAG GTC
ATC CAT GAC AAC-30 and 50-GAG GAG TGG GTG
TCG CTG TT-30; IRBP, 50-CAA GGT GCC CAC
GGT GCT-30 and 50-GGC CAC TGA CCT CAT GTC
GAT-30; CRX, 50-TCA AGA ACC GGA GGG CTA
AAT-30 and 50-ATA GCT CTG GCC TGA TAGGGA-
30; and opsin, 50-ACC ACA CAG AAG GCA GAG
AAG GAG-30 and 50-ATG ACA GGG TTG TAG
ATG GCG G-30.
Numerical data are group means  standard errors of
the mean (SEM). Statistical diﬀerences were determined
by Student’s unpaired t-test or by simple analysis of
variance followed by Newman–Keuls post hoc analysis
as noted in Results. Experiments were repeated 3–7
times as indicated in legends.
3. Results
Treatment of retinoblastoma cells with varying con-
centrations of butyrate had biphasic eﬀects on IRBP and
CRX mRNAs levels (Fig. 1). For IRBP mRNA, treat-
ment with butyrate stimulated mRNA levels, with the
eﬀect peaking between 0.05 and 0.2 mM butyrate and
producing about a ﬁve fold increase over untreated
controls (Fig. 1). Higher concentrations suppressed
mRNA below control levels (Fig. 1). For CRX mRNA,
treatment with butyrate stimulated mRNA levels, with
the eﬀect peaking at 0.1 mM butyrate and producing
about a three fold increase over untreated controls
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(Fig. 1). Higher concentrations suppressed mRNA be-
low control levels (Fig. 1). Even at the highest concen-
trations tested, butyrate treatment did not alter cell
counts, morphology, or protein content of cultures (data
not shown).
The eﬀect of retinoic acid on IRBP and CRX mRNA
in retinoblastoma cells was minimal and variable (Fig.
2). Additional experiments testing the eﬀects of retinoic
acid at 4, 8, 21, 28, and 48 h of treatment similarly
showed no eﬀect on IRBP or CRX transcript levels
(data not shown). Testing the eﬀect of retinoic acid
treatment on opsin mRNA was precluded because opsin
mRNA could not be detected in WERI cells via our RT-
RT-PCR assay (data not shown). This is in agreement
with previous work demonstrating lack of opsin im-
munoreactivity in WERI cells (Herman et al., 1989).
The lack of eﬀect of retinoic acid on IRBP mRNA
levels was unexpected. To further assess the eﬀect of
retinoic acid on IRBP promoter activity, cells were
treated with retinoic acid and transiently transfected
with IRBP/CAT promoter plasmid constructs. Treat-
ment with 10 lM retinoic acid (ﬁnal concentration) had
no signiﬁcant eﬀect on CAT activity (Table 1). No eﬀect
was seen across a 1–100 lM range of retinoic acid
concentrations (data not shown).
Contrary to results with retinoic acid, treatment with
retinol stimulated CRX mRNA levels with increasing
concentration (Fig. 3). The eﬀect of retinol on IRBP was
minimally stimulatory and not statistically signiﬁcant
(Fig. 3). Treatment with either butyrate or the retinoids
had no signiﬁcant or consistent eﬀect, relative to total
RNA concentration or protein content of individual
samples, on GAPDH mRNA levels (data not shown).
4. Discussion
Treatment of WERI-Rb1 retinoblastoma cells with
butyrate produced a concentration-dependent biphasic
eﬀect on CRX and IRBP transcript levels. To our
knowledge, this is the ﬁrst report of an eﬀect of butyrate
or any pharmacological agent on CRX gene expression.
As CRX is considered an important regulator of de-
velopment in the retina (Chen et al., 1997; Furukawa
et al., 1997), it may not be surprising that butyrate, a
compound commonly used to induce diﬀerentiation, has
eﬀects on CRX transcript levels. The eﬀect of butyrate
on homeodomain protein expression is relatively un-
studied. Butyrate stimulates the expression of Hox1.6 in
Fig. 1. Eﬀect of butyrate on IRBP and CRX mRNA levels retino-
blastoma cells were incubated 16 h in the presence of various con-
centrations of butyrate as indicated. Following incubation, total RNA
was isolated and used as template in RT-RT-PCRs with primers spe-
ciﬁc for GAPDH, IRBP, or CRX. Data represent the fold diﬀerence
between mRNA estimates (corrected against GAPDH signal) from
treated and untreated groups. 	P < 0:05 vs respective untreated group.
N ¼ 3–5 per data point. CRX data points are squares; IRBP data
points are circles.
Fig. 2. Eﬀect of retinoic acid on IRBP and CRX mRNA levels reti-
noblastoma cells were incubated 16 h in the presence of various con-
centrations of retinoic acid as indicated. Following incubation, total
RNA was isolated and used as template in RT-RT-PCRs with primers
speciﬁc for GAPDH, IRBP, or CRX. Data represent the fold diﬀer-
ence between mRNA estimates (corrected against GAPDH signal)
from treated and untreated groups. Treatment caused no signiﬁcant
eﬀect. N ¼ 4–5 per data point. CRX data points are squares; IRBP
data points are circles.
Table 1
Eﬀect of retinoic acid on IRBP promoter activity
Promoter Untreated Treated
1783/þ101 125 20 129 11
156/þ101 210 53 290 47
WERI-RB1 retinoblastoma cells were transiently transfected with
CAT reporter constructs containing a 1783/þ101 or a 156/þ101
mouse IRBP promoter fragment and then incubated with or without
10 lM retinoic acid. Both reporter fragments contain putative RAREs.
CAT activity is reported as CAT enzyme units 105, and represent the
mean of 3 repeats  SEM per group. No eﬀect was obtained.
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teratocarcinoma F9 cells (Iwai et al., 1995) and PDX-1
in cultured rat pancreatic acini (Rooman, Heremans,
Heimberg, & Bouwens, 2000). Though a likely mecha-
nism of action for butyrate is via histone deactelyase
inhibition (Jung, 2001; Riggs, Whittaker, Neumann, &
Ingram, 1977), it is unclear how this mechanism would
regulate speciﬁc homeodomain transcription factors.
The eﬀect of butyrate on IRBP transcript levels is in
partial agreement with that found previously in Y-79
retinoblastoma cells (Kyritsis et al., 1985). However, the
stimulatory eﬀect we ﬁnd occurred at much lower con-
centrations of butyrate than in Y-79 cells, whereas
the concentrations found to increase IRBP synthesis in
Y-79 cells (2–4 mM) (Kyritsis et al., 1985) are inhibi-
tory in WERI cells. The suppressive eﬀect appears to be
somewhat speciﬁc as no changes were observed in cell
counts, gross morphology, or total protein content
across culture samples.
Retinol treatment produced a concentration-depen-
dent rise in CRX transcript levels. To our knowledge,
this is the ﬁrst report of eﬀects of retinoids on CRX
expression. Conversely, retinoic acid, a biologically ac-
tive retinol metabolite (Ross et al., 2000) that activates
transcription of other retinal genes such as opsin
(Picking et al., 1996; Sun, Chen, Harrelson, & Stark,
1993) and arrestin (Wagner et al., 1997), had little eﬀect
on either IRBP or CRX transcript levels (Fig. 2). Be-
cause of this surprising result, we tested whether retinoic
acid treatment stimulates IRBP promoter activity. Us-
ing a transient transfection assay with which we have
much experience, we found that retinoic acid had no
eﬀect on reporter gene activity driven by two diﬀerent
IRBP promoter fragments, both containing putative
RAREs (Table 1). It is unusual for retinol to have an
eﬀect while retinoic acid has none, but it is perhaps not
surprising that retinol, a retinoid of central importance
to the visual cycle, may aﬀect the transcription of
photoresponsive genes; such a regulatory mechanism
might be expected to be unique to the photoreceptor
cell.
The relative eﬀects of the two retinoids resemble those
found in dispersed chicken retina cell cultures, where
retinol much more potently induced diﬀerentiation than
retinoic acid, and did so without ﬁrst being metabolized
into retinoic acid (Stenkamp, Gregory, & Adler, 1993).
The authors of that work postulated that retinol may
have direct eﬀects on photoreceptor progenitor cells,
possibly by binding an as-yet unidentiﬁed retinol-selec-
tive retinoid nuclear receptor (Stenkamp et al., 1993).
The data presented here are not at variance with that
working hypothesis. Alternatively, it has been suggested
that retinol may act as a photoreceptor-speciﬁc survival
factor (Fuhrmann, Heller, Rohrer, & Hofmann, 1998).
Increased survival of CRX-expressing cells could un-
derlie the quadrupling eﬀect of retinol on CRX tran-
script levels, though its lack of eﬀect on cell density and
IRBP transcript level do not support this explanation.
The minimal eﬀects of retinol on IRBP mRNA levels
may suggest a non-CRX mediated pathway to control
IRBP transcript levels. Though treatment with butyrate
causes a somewhat parallel change in the transcript
levels of the two genes, the large stimulatory eﬀect of
retinol on CRX mRNA level was not mimicked in IRBP
mRNA level. It may be that other homeobox proteins
regulate IRBP endogenously (Kimura et al., 2000;
Livesey, Furukawa, Steﬀen, Church, & Cepko, 2000;
Bobola et al., 1999; Briata et al., 1999; Fong & Fong,
1999). Alternatively, the current data may simply indi-
cate that the homeobox consensus element in the IRBP
promoter is fully occupied with endogenous transcrip-
tion factors in WERI cells, as suggested by CRX over-
expression experiments (Zhu & Craft, 2000). If either
condition exists, increases in CRX levels would not be
expected to dramatically increase IRBP expression.
Butyrate and retinoid treatment had no eﬀect on
GAPDH mRNA level, allowing its use as a normali-
zaton factor in analyzing the eﬀects of treatments on
CRX and IRBP mRNA levels. That these compounds
had no eﬀect on a constitutively active gene while al-
tering transcript levels of genes associated with various
states of photoreceptor diﬀerentiation may underscore
their potential use as diﬀerentiation agents in retinal
gene studies.
These experiments contribute to studies of CRX and
IRBP gene expression by identifying two pharmacolo-
gical tools, butyrate and retinol, that robustly aﬀect
IRBP and CRX mRNA levels. There is an unexpected
Fig. 3. Eﬀect of retinol on IRBP and CRX mRNA levels retinoblas-
toma cells were incubated 16 h in the presence of various concentra-
tions of all-trans retinol as indicated. Following incubation, total RNA
was isolated and used as template in RT-RT-PCRs with primers spe-
ciﬁc for GAPDH, IRBP, or CRX. Data represent the fold diﬀerence
between mRNA estimates (corrected against GAPDH signal) from
treated and untreated groups. 	P < 0:05 vs respective untreated group.
N ¼ 3–7 per data point. CRX data points are squares; IRBP data
points are circles.
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selectivity for the action of the two retinoids in regards to
CRX, with retinol active and retinoic acid inactive. In-
terestingly, the stimulatory eﬀect of retinol on CRX
mRNA level is speciﬁc in that little eﬀect is seen on an-
other retina-selective gene, IRBP. Thus, retinol might
be a useful tool for manipulating CRX expression, par-
ticularly in conjunction with other pharmacological
manipulations that suppress CRX expression (Boatright,
Borst, et al., 2001). As mRNA amounts are altered, the
regulation provided by retinol or butyrate may be at the
level of transcription or mRNA degradation.
Acknowledgements
Funded by NIH P30 EY6360, R01 EY12514, and
R01 EY9378, Research to Prevent Blindness, Fight For
Sight, the Foundation Fighting Blindness, and the
Knights Templar Foundation.
References
Bang, A. G., Papalopulu, N., Kintner, C., & Goulding, M. D. (1997).
Expression of Pax-3 is initiated in the early neural plate by
posteriorizing signals produced by the organizer and by posterior
non-axial mesoderm. Development, 124, 2075–2085.
Boatright, J. H., Borst, D. E., Peoples, J. W., Bruno, J., Edwards,
C. L., Si, J. S., & Nickerson, J. M. (1997). A major cis activator of
the IRBP gene contains CRX-binding and Ret-1/PCE-I elements.
Molecular Vision, 3, 15–24.
Boatright, J. H., Borst, D. E., Stodulkova, E., & Nickerson, J. M.
(2001). Endogenous CRX expression and IRBP promoter activity
in retinoblastoma cells. Brain Research, 916, 136–142.
Boatright, J. H., Buono, R., Bruno, J., Lang, R., Si, J. S., Shinohara,
T., Peoples, J. W., & Nickerson, J. M. (1997). The 50 ﬂanking
regions of mouse IRBP and arrestin have promoter activity in
primary embryonic chicken retina cell cultures. Experimental Eye
Research, 64, 269–277.
Boatright, J. H., Knox, B. E., Jones, K. M., Stodulkova, E., Nguyen,
H. T., Padove, S. A., Borst, D. E., & Nickerson, J. M. (2001).
Evidence of a tissue-restricting DNA regulatory element in the
mouse IRBP promoter. FEBS Letters, 504, 27–30.
Boatright, J. H., Nickerson, J. M., & Borst, D. E. (2000). Site-speciﬁc
DNA hypomethylation permits expression of the IRBP gene. Brain
Research, 887, 211–221.
Bobola, N., Briata, P., Ilengo, C., Rosatto, N., Craft, C., Corte, G., &
Ravazzolo, R. (1999). OTX2 homeodomain protein binds a DNA
element necessary for interphotoreceptor retinoid binding protein
gene expression. Mechanisms of Development, 82, 165–169.
Briata, P., Ilengo, C., Bobola, N., & Corte, G. (1999). Binding
properties of the human homeodomain protein OTX2 to a DNA
target sequence. FEBS Letters, 445, 160–214.
Bunt-Milam, A. H., & Saari, J. C. (1983). Immunocytochemical
localization of two retinoid-binding proteins in vertebrate retina.
Journal of Cell Biology, 97, 703–712.
Carlson, A., & Bok, D. (1992). Promotion of the release of 11-cis-
retinal from cultured retinal pigment epithelium by interphotore-
ceptor retinoid-binding protein. Biochemistry, 31, 9056–9062.
Chariot, A., Moreau, L., Senterre, G., Sobel, M. E., & Castronovo, V.
(1995). Retinoic acid induces three newly cloned HOXA1 tran-
scripts in MCF7 breast cancer cells. Biochemical and Biophysical
Research Commununication, 215, 713–720.
Chen, S., Wang, Q. L., Nie, Z., Sun, H., Lennon, G., Copeland,
N. G., Gilbert, D. J., Jenkins, N. A., & Zack, D. J. (1997). Crx, a
novel Otx-like paired-homeodomain protein, binds to and trans-
activates photoreceptor cell-speciﬁc genes. Neuron, 19, 1017–
1030.
Fong, S. L., & Fong, W. B. (1999). Elements regulating the
transcription of human interstitial retinoid-binding protein (IRBP)
gene in cultured retinoblastoma cells. Current Eye Research, 18,
283–291.
Fuhrmann, S., Heller, S., Rohrer, H., & Hofmann, H. D. (1998). A
transient role for ciliary neurotrophic factor in chick photoreceptor
development. Journal of Neurobiology, 37, 672–683.
Furukawa, T., Morrow, E. M., & Cepko, C. L. (1997). Crx, a novel
otx-like homeobox gene, shows photoreceptor-speciﬁc expression
and regulates photoreceptor diﬀerentiation. Cell, 91, 531–541.
Gaunt, S. J. (1991). Expression patterns of mouse Hox genes: clues to
an understanding of developmental and evolutionary strategies.
Bioessays, 13, 505–513.
Giguere, V., Ong, E. S., Segui, P., & Evans, R. M. (1987). Identiﬁcation
of a receptor for the morphogen retinoic acid. Nature, 330, 624–
629.
Herman, M. M., Perentes, E., Katsetos, C. D., Darcel, F., Frankfurter,
A., Collins, V. P., Donoso, L. A., Eng, L. F., Marangos, P. J.,
& Wiechmann, A. F., et al. (1989). Neuroblastic diﬀerentiation
potential of the human retinoblastoma cell lines Y-79 and
WERI-Rb1 maintained in an organ culture system. An immu-
nohistochemical, electron microscopic, and biochemical study.
American Journal of Pathology, 134(1), 115–132.
Houle, M., Prinos, P., Iulianella, A., Bouchard, N., & Lohnes, D.
(2000). Retinoic acid regulation of Cdx1: an indirect mechanism for
retinoids and vertebral speciﬁcation. Molecular Cell Biology, 20,
6579–6586.
Iwai, S. A., Nishina, Y., Kosaka, M., Sumi, T., Doi, T., Sakuda, M.,
& Nishimune, Y. (1995). The kinetics of induction of Hox1.6 and
C-jun mRNA during three diﬀerent ways of inducing diﬀerentia-
tion in teratocarcinoma F9 cells. In Vitro Cellular Developmental
Biology. Animal, 31, 462–466.
Jung, M. (2001). Inhibitors of histone deacetylase as new anticancer
agents. Current Medical Chemistry, 8, 1505–2111.
Katz, M. L., Gao, C. L., & Stientjes, H. J. (1993). Regulation of the
interphotoreceptor retinoid-binding protein content of the retina
by Vitamin A. Experimental Eye Research, 57, 393–401.
Kimura, A., Singh, D., Wawrousek, E. F., Kikuchi, M., Nakamura,
M., & Shinohara, T. (2000). Both PCE-1/RX and OTX/CRX
interactions are necessary for photoreceptor-speciﬁc gene expres-
sion. Journal of Biological Chemistry, 275, 1152–1160.
Kyritsis, A. P., Wiggert, B., Lee, L., & Chader, G. J. (1985). Butyrate
enhances the synthesis of interphotoreceptor retinoid-bind protein
(IRBP) by Y-79 human retinoblastoma cells. Journal of Cell
Physiology, 124, 233–239.
Lindberg, C., Wunderlich, M. J., Dinsmore, J., & Jacoby, D. B. (1998).
Ratliﬀ. Regulated expression of the homeobox gene, rPtx2, in the
developing rat. Brain Research Developmental Brain Research, 110,
215–226.
Liou, G. I., Fei, Y., Peachey, N. S., Matragoon, S., Wei, S., Blaner, W.
S., Wang, Y., Liu, C., Gottesman, M. E., & Ripps, H. (1998). Early
onset photoreceptor abnormalities induced by targeted disruption
of the interphotoreceptor retinoid-binding protein gene. Journal of
Neuroscience, 18, 4511–4520.
Liou, G. I., Matragoon, S., Chen, D. M., Gao, C. L., Zhang, L., Fei,
Y., Katz, M. L., & Stark, W. S. (1998). Visual sensitivity and
interphotoreceptor retinoid binding protein in the mouse: regula-
tion by vitamin A. FASEB Journal, 12, 129–138.
Liou, G. I., Wang, M., & Matragoon, S. (1994). Timing of interpho-
toreceptor retinoid-binding protein IRBP gene expression and
hypomethylation in developing mouse retina. Developmental Bio-
logy, 161, 345–356.
J.H. Boatright et al. / Vision Research 42 (2002) 933–938 937
Livesey, F. J., Furukawa, T., Steﬀen, M. A., Church, G. M., & Cepko,
C. L. (2000). Microarray analysis of the transcriptional network
controlled by the photoreceptor homeobox gene Crx. Current
Biology, 10, 301–310.
Okajima, T.-I. L., Pepperberg, D. R., Ripps, H., Wiggert, B., &
Chader, G. J. (1989). Interphotoreceptor retinoid-binding protein:
Role in the delivery of retinol to the pigment epithelium.
Experimental Eye Research, 49, 629–644.
Okajima, T. I., Pepperberg, D. R., Ripps, H., Wiggert, B., & Chader,
G. J. (1990). Interphotoreceptor retinoid-binding protein promotes
rhodopsin regeneration in toad photoreceptors. Proceedings of
National Academy of Science (USA), 87, 6907–6911.
Petkovich, M., Brand, N. J., Krust, A., & Chambon, P. (1987). A
human retinoic acid receptor which belongs to the family of nuclear
receptors. Nature, 330, 444–450.
Picking, W. L., Chen, D. M., Lee, R. D., Vogt, M. E., Polizzi, J. L.,
Marietta, R. G., & Stark, W. S. (1996). Control of Drosophila
opsin gene expression by carotenoids and retinoic acid: northern
and western analyses. Experimental Eye Research, 63, 493–500.
Riggs, M. G., Whittaker, R. G., Neumann, J. R., & Ingram, V. M.
(1977). n-Butyrate causes histone modiﬁcation in HeLa and Friend
erythroleukaemia cells. Nature, 268, 462–464.
Rooman, I., Heremans, Y., Heimberg, H., & Bouwens, L. (2000).
Modulation of rat pancreatic acinoductal transdiﬀerentiation and
expression of PDX-1 in vitro. Diabetologia, 43, 907–914.
Ross, S. A., McCaﬀery, P. J., Drager, U. C., & DeLuca, L. M. (2000).
Retinoids in embryonal development. Physiological Reviews, 80,
1021–1054.
Simeone, A., Acampora, D., Nigro, V., Faiella, A., D’Esposito, M.,
Stornaiuolo, A., Mavilio, F., & Boncinelli, E. (1991). Diﬀerential
regulation by retinoic acid of the homeobox genes of the four HOX
loci in human embryonal carcinoma cells. Mechanisms of Devel-
opments, 33, 215–227.
Simeone, A., Acampora, D., Arcioni, L., Andrews, P. W., Boncinelli,
E., & Mavilio, F. (1990). Sequential activation of HOX2 homeobox
genes by retinoic acid in human embryonal carcinoma cells. Nature,
346, 763–766.
Stenkamp, D. L., Cunningham, L. L., Raymond, P. A., & Gonzalez-
Fernandez, F. (1998). Novel expression pattern of interphotore-
ceptor retinoid-binding protein (IRBP) in the adult and developing
zebraﬁsh retina and RPE. Molecular Vision, 4, 26–39.
Stenkamp, D. L., Gregory, J. K., & Adler, R. (1993). Retinoid eﬀects
in puriﬁed cultures of chick embryo retina neurons and photore-
ceptors. Investigative Opthalmology and Visual Science, 34, 2425–
2436.
Sun, D., Chen, D. M., Harrelson, A., & Stark, W. S. (1993). Increased
expression of chloramphenicol acetyltransferase by carotenoid and
retinoid replacement in Drosophila opsin promoter fusion stocks.
Experimental Eye Research, 57, 177–187.
van Veen, T., Katial, A., Shinohara, T., Barrett, D. J., Wiggert, B.,
Chader, G. J., & Nickerson, J. M. (1986). Retinal photoreceptor
neurons and pinealocytes accumulate mRNA for interphotorecep-
tor retinoid-binding protein (IRBP). FEBS Letters, 208, 133–137.
Wagner, E., McCaﬀery, P., Mey, J., Farhangfar, F., Applebury, M. L.,
& Drager, U. C. (1997). Retinoic aid increases arrestin mRNA
levels in the mouse retina. FASEB Journal, 11, 271–275.
938 J.H. Boatright et al. / Vision Research 42 (2002) 933–938
